News

Poniard Pharmaceuticals has reported new positive efficacy and safety data from its ongoing Phase II clinical trial of picoplatin in combination with docetaxel and prednisone as first-line therapy

US-based healthcare company Abbott has opened a new nutrition product manufacturing facility in Singapore to meet increasing regional demand for its pediatric nutrition products, including Similac. The facility

Cardiovascular Systems, a medical device company, has closed its merger with a subsidiary of Replidyne. In connection with the merger, Replidyne changed its name to Cardiovascular Systems, Inc

We made a major strategic acquisition to purchase SPR technology and sold our HIFU business to become a pure advanced IVD company based in China,” commented Xiaodong Wu,

China Sky One Medical, a producer of over-the-counter drugs, has signed an agreement with Shaanxi Xintai Pharmaceutical Company to distribute the company’s Asthma Patch product. Shaanxi Xintai and

Bone Biologics has received a US Patent Office notice of allowance of patent claims which protect a method of production for the UCB-1 recombinant protein that the company

Brecher is a member of the editorial boards of Transfusion and Blood Therapies in Medicine and is an associate editor of the Journal of Clinical Apheresis. He is

The Astellas tender offer represents a 41% premium to CV Therapeutics’s closing share price on January 26, 2009, the day prior to the public disclosure of Astellas’s proposal,

Under its bid, Cephalon intends to offer A$1.40 cash for each Arana ordinary share cum dividends and other rights. The total offer value is approximately A$318 million. The